Chappell M C, Diz D I, Yunis C, Ferrario C M
Hypertension and Vascular Center, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
Kidney Int Suppl. 1998 Dec;68:S3-6. doi: 10.1038/sj.ki.4490555.
Angiotensin-(1-7) is a bioactive component of the renin-angiotensin system that is endogenously formed in the circulation and various tissues by several enzymatic pathways from either angiotensin (Ang) I or Ang II. Initial studies indicated that Ang-(1-7) mimicked some of the effects of Ang II, including stimulation of release of prostanoids and vasopressin. However, Ang-(1-7) is devoid of the vasoconstrictor, central pressor, or thirst-stimulating actions associated with Ang II. In fact, new findings reveal depressor, vasodilator, and antihypertensive actions that may be more apparent in hypertensive animals or humans. Thus, increasing evidence suggests that Ang-(1-7) may oppose the actions of Ang II directly or as a result of increasing prostaglandins or nitric oxide. In this review, we examine recent studies to address whether the kidney is a target organ for antihypertensive actions of Ang-(1-7).
血管紧张素 -(1 - 7)是肾素 - 血管紧张素系统的一种生物活性成分,它通过几种酶促途径在循环系统和各种组织中由血管紧张素(Ang)I 或 Ang II 内源性生成。最初的研究表明,血管紧张素 -(1 - 7)模拟了血管紧张素 II 的一些作用,包括刺激前列腺素和血管加压素的释放。然而,血管紧张素 -(1 - 7)没有与血管紧张素 II 相关的血管收缩、中枢升压或刺激口渴的作用。事实上,新的研究结果揭示了降压、血管舒张和抗高血压作用,这些作用在高血压动物或人类中可能更为明显。因此,越来越多的证据表明,血管紧张素 -(1 - 7)可能直接对抗血管紧张素 II 的作用,或者由于前列腺素或一氧化氮增加而产生这种作用。在这篇综述中,我们研究了最近的研究,以探讨肾脏是否是血管紧张素 -(1 - 7)抗高血压作用的靶器官。